Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,955 | 17,085 | 6,227 | -19,536 | 15,909 |
| Depreciation Amortization | 74,746 | 60,128 | 40,987 | 21,214 | 98,708 |
| Income taxes - deferred | 15,615 | 9,014 | 4,100 | -7,342 | -7,945 |
| Accounts receivable | -7,159 | 1,440 | -683 | 5,192 | -2,079 |
| Accounts payable and accrued liabilities | 916 | 1,988 | 9,683 | 2,628 | 6,272 |
| Other Working Capital | -44,625 | -33,978 | -28,569 | -15,719 | -16,433 |
| Other Operating Activity | 73,201 | 51,388 | 30,882 | 32,691 | 50,842 |
| Operating Cash Flow | $154,649 | $107,065 | $62,627 | $19,128 | $145,274 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,758 | N/A | N/A | N/A | -13,000 |
| PPE Investments | -15,161 | -13,363 | -9,969 | -6,565 | -30,076 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -32,000 |
| Purchase Of Investment | -137,608 | -118,440 | -76,267 | -53,497 | -387,685 |
| Sale Of Investment | 237,068 | 200,970 | 159,745 | 126,245 | 237,576 |
| Investing Cash Flow | $77,541 | $69,167 | $73,509 | $66,183 | $-225,185 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 149,550 | 149,550 | 149,550 | 149,550 | N/A |
| Debt Repayment | -330,312 | -327,500 | -299,688 | -296,875 | -427,694 |
| Common Stock Issued | 4,750 | 3,611 | 3,586 | 333 | 27,341 |
| Other Financing Activity | -7,019 | -6,913 | -6,913 | -6,913 | -1,175 |
| Financing Cash Flow | $-183,031 | $-181,252 | $-153,465 | $-153,905 | $-401,528 |
| Beginning Cash Position | 104,139 | 104,139 | 104,139 | 104,139 | 585,578 |
| End Cash Position | 153,298 | 99,119 | 86,810 | 35,545 | 104,139 |
| Net Cash Flow | $49,159 | $-5,020 | $-17,329 | $-68,594 | $-481,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,649 | 107,065 | 62,627 | 19,128 | 145,274 |
| Capital Expenditure | -15,161 | -13,363 | -9,969 | -6,565 | -30,076 |
| Free Cash Flow | 139,488 | 93,702 | 52,658 | 12,563 | 115,198 |